Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neuroinflammation
Published in: Journal of Neuroinflammation 1/2012

Open Access 01-12-2012 | Research

Small interfering RNA-mediated suppression of Ccl2 in Müller cells attenuates microglial recruitment and photoreceptor death following retinal degeneration

Authors: Matt Rutar, Riccardo Natoli, Jan M Provis

Published in: Journal of Neuroinflammation | Issue 1/2012

Login to get access

Abstract

Background

The recruitment and activation of inflammatory cells is thought to exacerbate photoreceptor death in retinal degenerative conditions such as age-related macular degeneration (AMD). We investigated the role of Müller cell-derived chemokine (C-C motif) ligand (Ccl)2 expression on monocyte/microglia infiltration and photoreceptor death in light-mediated retinal degeneration, using targeted small interfering (si)RNA.

Methods

Adult Sprague–Dawley rats were injected intravitreally with 1 μg of either Ccl2 siRNA or scrambled siRNA, and were then exposed to 1000 lux of light for a period of 24 hours. The mice were given an overdose of barbiturate, and the retinas harvested and evaluated for the effects of bright-light exposure. Ccl2 expression was assessed by quantitative PCR, immunohistochemistry, and in situ hybridization. Monocytes/microglia were counted on retinal cryostat sections immunolabeled with the markers ED1 and ionized calcium binding adaptor (IBA)1, and photoreceptor apoptosis was assessed using terminal dUTP nick end labeling.

Results

Intravitreal injection of Ccl2 siRNA significantly reduced the expression of Ccl2 following light damage to 29% compared with controls. In retinas injected with Ccl2 siRNA, in situ hybridization and immunohistochemistry on retinal cryostat sections showed a substantial decrease in Ccl2 within Müller cells. Cell counts showed significantly fewer ED1-positive and IBA1-positive cells in the retinal vasculature and outer nuclear layer of Ccl2 siRNA-injected retinas, compared with controls. Moreover, there was significantly less photoreceptor apoptosis in Ccl2 siRNA-injected retinas compared with controls.

Conclusions

Our data indicate that Ccl2 expression by Müller cells promotes the infiltration of monocytes/microglia, thereby contributing to the neuroinflammatory response and photoreceptor death following retinal injury. Modulation of exaggerated chemokine responses using siRNA may have value in reducing inflammation-mediated cell death in retinal degenerative disease such as AMD.
Literature
1.
Bauer J, Sminia T, Wouterlood FG, Dijkstra CD: Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis. J Neurosci Res 1994, 38:365–375.PubMedCrossRef
2.
Gupta N, Brown KE, Milam AH: Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp Eye Res 2003, 76:463–471.PubMedCrossRef
3.
Neumann H, Kotter MR, Franklin RJ: Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009, 132:288–295.PubMedCrossRef
4.
Penfold PL, Liew SC, Madigan MC, Provis JM: Modulation of major histocompatibility complex class II expression in retinas with age-related macular degeneration. Invest Ophthalmol Vis Sci 1997, 38:2125–2133.PubMed
5.
Penfold PL, Provis JM, Liew SC: Human retinal microglia express phenotypic characteristics in common with dendritic antigen-presenting cells. J Neuroimmunol 1993, 45:183–191.PubMedCrossRef
6.
Mattiace LA, Davies P, Dickson DW: Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol 1990, 136:1101–1114.PubMedPubMedCentral
7.
Matsubara T, Pararajasegaram G, Wu GS, Rao NA: Retinal microglia differentially express phenotypic markers of antigen-presenting cells in vitro. Invest Ophthalmol Vis Sci 1999, 40:3186–3193.PubMed
8.
Nakajima K, Kohsaka S: Microglia: neuroprotective and neurotrophic cells in the central nervous system. Curr Drug Targets Cardiovasc Haematol Disord 2004, 4:65–84.PubMedCrossRef
9.
10.
11.
Wirenfeldt M, Babcock AA, Vinters HV: Microglia - insights into immune system structure, function, and reactivity in the central nervous system. Histol Histopathol 2011, 26:519–530.PubMed
12.
Ezzat MK, Hann CR, Vuk-Pavlovic S, Pulido JS: Immune cells in the human choroid. Br J Ophthalmol 2008, 92:976–980.PubMedCrossRef
13.
Penfold PL, Killingsworth MC, Sarks SH: Senile macular degeneration. The involvement of giant cells in atrophy of the retinal pigment epithelium. Invest Ophthalmol Vis Sci 1986, 27:364–271.PubMed
14.
Wong J, Madigan M, Billson F, Penfold P: Quantification of leukocyte common antigen (CD45) expression in macular degeneration. Invest Ophthalmol Vis Sci 2001, 42:S227.
15.
Cherepanoff S, McMenamin P, Gillies MC, Kettle E, Sarks SH: Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration. Br J Ophthalmol 2009, 94:918–925.PubMedCrossRef
16.
Lewis GP, Sethi CS, Carter KM, Charteris DG, Fisher SK: Microglial cell activation following retinal detachment: a comparison between species. Mol Vis 2005, 11:491–500.PubMed
17.
Vrabec F: Activated human retinal microglia under pathological conditions. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1975, 196:49–60.PubMedCrossRef
18.
Yuan L, Neufeld AH: Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res 2001, 64:523–532.PubMedCrossRef
19.
Neufeld AH: Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch Ophthalmol 1999, 117:1050–1056.PubMedCrossRef
20.
Zeng HY, Green WR, Tso MO: Microglial activation in human diabetic retinopathy. Arch Ophthalmol 2008, 126:227–232.PubMedCrossRef
21.
Yang LP, Zhu XA, Tso MO: A possible mechanism of microglia-photoreceptor crosstalk. Mol Vis 2007, 13:2048–2057.PubMed
22.
Roque RS, Rosales AA, Jingjing L, Agarwal N, Al-Ubaidi MR: Retina-derived microglial cells induce photoreceptor cell death in vitro. Brain Res 1999, 836:110–119.PubMedCrossRef
23.
Boje KM, Arora PK: Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 1992, 587:250–256.PubMedCrossRef
24.
Chao CC, Hu S, Ehrlich L, Peterson PK: Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 1995, 9:355–365.PubMedCrossRef
25.
McGuire SO, Ling ZD, Lipton JW, Sortwell CE, Collier TJ, Carvey PM: Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Exp Neurol 2001, 169:219–230.PubMedCrossRef
26.
Sawada M, Kondo N, Suzumura A, Marunouchi T: Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res 1989, 491:394–397.PubMedCrossRef
27.
28.
29.
Garden GA, Moller T: Microglia biology in health and disease. J Neuroimmune Pharmacol 2006, 1:127–137.PubMedCrossRef
30.
Kataoka K, Nishiguchi KM, Kaneko H, van Rooijen N, Kachi S, Terasaki H: The roles of vitreal macrophages and circulating leukocytes in retinal neovascularization. Invest Ophthalmol Vis Sci 2011, 14:1431–1438.CrossRef
31.
Hoppeler T, Hendrickson P, Dietrich C, Reme C: Morphology and time-course of defined photochemical lesions in the rabbit retina. Curr Eye Res 1988, 7:849–860.PubMedCrossRef
32.
Ni YQ, Xu GZ, Hu WZ, Shi L, Qin YW, Da CD: Neuroprotective effects of naloxone against light-induced photoreceptor degeneration through inhibiting retinal microglial activation. Invest Ophthalmol Vis Sci 2008, 49:2589–2598.PubMedCrossRef
33.
Chang CJ, Cherng CH, Liou WS, Liao CL: Minocycline partially inhibits caspase-3 activation and photoreceptor degeneration after photic injury. Ophthalmic Res 2005, 37:202–213.PubMedCrossRef
34.
Ibrahim AS, El-Shishtawy MM, Pena A Jr: Liou GI: genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol Vis 2010, 16:2033–2042.PubMedPubMedCentral
35.
Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, Levison SW: Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 2005, 54:1559–1565.PubMedCrossRef
36.
Bosco A, Inman DM, Steele MR, Wu G, Soto I, Marsh-Armstrong N, Hubbard WC, Calkins DJ, Horner PJ, Vetter ML: Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2 J mouse model of glaucoma. Invest Ophthalmol Vis Sci 2008, 49:1437–1446.PubMedCrossRef
37.
Neufeld AH: Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma. Brain Res Bull 2004, 62:455–459.PubMedCrossRef
38.
Yang LP, Li Y, Zhu XA, Tso MO: Minocycline delayed photoreceptor death in rds mice through iNOS-dependent mechanism. Mol Vis 2007, 13:1073–1082.PubMedPubMedCentral
39.
Karlstetter M, Ebert S, Langmann T: Microglia in the healthy and degenerating retina: insights from novel mouse models. Immunobiol 2010, 215:685–691.CrossRef
40.
Luster AD: Chemokines–chemotactic cytokines that mediate inflammation. N Engl J Med 1998, 338:436–445.PubMedCrossRef
41.
Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991, 9:617–648.PubMedCrossRef
42.
Bajetto A, Bonavia R, Barbero S, Schettini G: Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J Neurochem 2002, 82:1311–1329.PubMedCrossRef
43.
Ransohoff RM, Glabinski A, Tani M: Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev 1996, 7:35–46.PubMedCrossRef
44.
45.
Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ: Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989, 169:1485–1490.PubMedCrossRef
46.
Yoshimura T, Robinson EA, Tanaka S, Appella E, Kuratsu J, Leonard EJ: Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med 1989, 169:1449–1459.PubMedCrossRef
47.
Nakazawa T, Hisatomi T, Nakazawa C, Noda K, Maruyama K, She H, Matsubara A, Miyahara S, Nakao S, Yin Y, et al.: Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis. Proc Natl Acad Sci USA 2007, 104:2425–2430.PubMedPubMedCentralCrossRef
48.
Prat E, Baron P, Meda L, Scarpini E, Galimberti D, Ardolino G, Catania A, Scarlato G: The human astrocytoma cell line U373MG produces monocyte chemotactic protein (MCP)-1 upon stimulation with beta-amyloid protein. Neurosci Lett 2000, 283:177–180.PubMedCrossRef
49.
Johnstone M, Gearing AJ, Miller KM: A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced. J Neuroimmunol 1999, 93:182–193.PubMedCrossRef
50.
Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN: Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol 1998, 84:238–249.PubMedCrossRef
51.
McManus C, Berman JW, Brett FM, Staunton H, Farrell M, Brosnan CF: MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J Neuroimmunol 1998, 86:20–29.PubMedCrossRef
52.
Galimberti D, Venturelli E, Villa C, Fenoglio C, Clerici F, Marcone A, Benussi L, Cortini F, Scalabrini D, Perini L, et al.: MCP-1 A-2518 G polymorphism: effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels. J Alzheimers Dis 2009, 17:125–133.PubMed
53.
Glabinski AR, Balasingam V, Tani M, Kunkel SL, Strieter RM, Yong VW, Ransohoff RM: Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J Immunol 1996, 156:4363–4368.PubMed
54.
Muessel MJ, Berman NE, Klein RM: Early and specific expression of monocyte chemoattractant protein-1 in the thalamus induced by cotrical injury. Brain Res 2000, 870:211–221.PubMedCrossRef
55.
Rutar M, Natoli R, Valter K, Provis JM: Early focal expression of the chemokine Ccl2 by Müller cells during exposure to damage-inducing bright continuous light. Invest Ophthalmol Vis Sci 2011,52(5):2379–2388.PubMedPubMedCentralCrossRef
56.
Rutar M, Provis JM, Valter K: Brief exposure to damaging light causes focal recruitment of macrophages, and long-term destabilization of photoreceptors in the albino rat retina. Curr Eye Res 2010, 35:631–643.PubMedCrossRef
57.
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494–498.PubMedCrossRef
58.
Ameres SL, Martinez J, Schroeder R: Molecular basis for target RNA recognition and cleavage by human RISC. Cell 2007, 130:101–112.PubMedCrossRef
59.
Gao H, Pennesi M, Shah K, Qiao X, Hariprasad SM, Mieler WF, Wu SM, Holz ER: Safety of intravitreal voriconazole: electroretinographic and histopathologic studies. Trans Am Ophthalmol Soc 2003, 101:183–189. discussion 189PubMed
60.
Natoli R, Provis J, Valter K, Stone J: Gene regulation induced in the C57BL/6 J mouse retina by hyperoxia: a temporal microarray study. Mol Vis 2008, 14:1983–1994.PubMedPubMedCentral
61.
Cornish EE, Madigan MC, Natoli R, Hales A, Hendrickson AE, Provis JM: Gradients of cone differentiation and FGF expression during development of the foveal depression in macaque retina. Vis Neurosci 2005, 22:447–459.PubMedCrossRef
62.
Maslim J, Valter K, Egensperger R, et al.: Tissue oxygen during a critical developmental period controls the death and survival of photoreceptors. Invest Ophthalmol Vis Sci 1997, 38:1667–1677.PubMed
63.
Ng TF, Streilein JW: Light-induced migration of retinal microglia into the subretinal space. Invest Ophthalmol Vis Sci 2001, 42:3301–3310.PubMed
64.
Chen L, Yang P, Kijlsta A: Distribution, markers, and functions of retinal microglia. Ocul Immunol Inflamm 2002, 10:27–39.PubMedCrossRef
65.
Davoust N, Vuaillat C, Androdias G, Nataf S: From bone marrow to microglia: barriers and avenues. Trends Immunol 2008, 29:227–234.PubMedCrossRef
66.
Joly S, Francke M, Ulbricht E, Beck S, Seeliger M, Hirrlinger P, Hirrlinger J, Lang KS, Zinkernagel M, Odermatt B, et al.: Cooperative phagocytes: resident microglia and bone marrow immigrants remove dead photoreceptors in retinal lesions. Am J Pathol 2009, 174:2310–2323.PubMedPubMedCentralCrossRef
67.
Zhang C, Shen JK, Lam TT, Zeng HY, Chiang SK, Yang F, Tso MO: Activation of microglia and chemokines in light-induced retinal degeneration. Mol Vis 2005, 11:887–895.PubMed
68.
Shi G, Maminishkis A, Banzon T, Jalickee S, Li R, Hammer J, Miller SS: Control of chemokine gradients by the retinal pigment epithelium. Invest Ophthalmol Vis Sci 2008, 49:4620–4630.PubMedPubMedCentralCrossRef
69.
Elner SG, Elner VM, Bian ZM, Lukacs NW, Kurtz RM, Strieter RM, Kunkel SL: Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products. Invest Ophthalmol Vis Sci 1997, 38:446–455.PubMed
70.
Elner VM, Burnstine MA, Strieter RM, Kunkel SL, Elner SG: Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses. Exp Eye Res 1997, 65:781–789.PubMedCrossRef
71.
Bian ZM, Elner SG, Strieter RM, Kunkel SL, Lukacs NW, Elner VM: IL-4 potentiates IL-1beta- and TNF-alpha-stimulated IL-8 and MCP-1 protein production in human retinal pigment epithelial cells. Curr Eye Res 1999, 18:349–357.PubMedCrossRef
72.
Holtkamp GM, Kijlstra A, Peek R, de Vos AF: Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes. Prog Retin Eye Res 2001, 20:29–48.PubMedCrossRef
73.
Kaneko H, Nishiguchi KM, Nakamura M, Kachi S, Terasaki H: Characteristics of bone marrow-derived microglia in the normal and injured retina. Invest Ophthalmol Vis Sci 2008, 49:4162–4168.PubMedCrossRef
74.
Yoshimura T, Leonard EJ: Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes. J Immunol 1990, 145:292–297.PubMed
75.
Zhang J, Shi XQ, Echeverry S, Mogil JS, De Koninck Y, Rivest S: Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci 2007, 27:12396–12406.PubMedCrossRef
76.
Yang D, Elner SG, Chen X, Field MG, Petty HR, Elner VM: MCP-1-activated monocytes induce apoptosis in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2011, 52:6026–6034.PubMedPubMedCentralCrossRef
77.
Elner VM, Elner SG, Standiford TJ, Lukacs NW, Strieter RM, Kunkel SL: Interleukin-7 (IL-7) induces retinal pigment epithelial cell MCP-1 and IL-8. Exp Eye Res 1996, 63:297–303.PubMedCrossRef
78.
Palframan RT, Jung S, Cheng G, Weninger W, Luo Y, Dorf M, Littman DR, Rollins BJ, Zweerink H, Rot A, von Andrian UH: Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 2001, 194:1361–1373.PubMedPubMedCentralCrossRef
79.
Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C, Rollins BJ: Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998, 187:601–608.PubMedCrossRefPubMedCentral
80.
Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM: Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 2001, 193:713–726.PubMedPubMedCentralCrossRef
81.
Thompson WL, Karpus WJ, Van Eldik LJ: MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult. J Neuroinflammation 2008, 5:35.PubMedPubMedCentralCrossRef
82.
Joly S, Samardzija M, Wenzel A, Thiersch M, Grimm C: Nonessential role of beta3 and beta5 integrin subunits for efficient clearance of cellular debris after light-induced photoreceptor degeneration. Invest Ophthalmol Vis Sci 2009, 50:1423–1432.PubMedCrossRef
83.
84.
Wenzel A, Grimm C, Samardzija M, Remé CE: Molecular mechanisms of light induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Ret Eye Res 2005, 24:275–306.CrossRef
85.
Sullivan R, Penfold P, Pow DV: Neuronal migration and glial remodeling in degenerating retinas of aged rats and in nonneovascular AMD. Invest Ophthalmol Vis Sci 2003, 44:856–865.PubMedCrossRef
86.
Marco-Gomariz MA, Hurtado-Montalban N, Vidal-Sanz M, Lund RD, Villegas-Perez MP: Phototoxic-induced photoreceptor degeneration causes retinal ganglion cell degeneration in pigmented rats. J Comp Neurol 2006, 498:163–179.PubMedCrossRef
87.
Marc RE, Jones BW, Watt CB, Vazquez-Chona F, Vaughan DK, Organisciak DT: Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration. Mol Vis 2008, 14:782–806.PubMedPubMedCentral
88.
Rapaport DH, Stone J: The area centralis of the retina in the cat and other mammals: focal point for function and development of the visual system. Neuroscience 1984, 11:289–301.PubMedCrossRef
89.
Fukuda Y: A three-group classification of rat retinal ganglion cells: histological and physiological studies. Brain Res 1977, 119:327–344.PubMedCrossRef
90.
Rowe MH, Dreher B: Functional morphology of beta cells in the area centralis of the cat's retina: a model for the evolution of central retinal specializations. Brain Behav Evol 1982, 21:1–23.PubMedCrossRef
91.
Espinosa-Heidmann DG, Suner IJ, Hernandez EP, Monroy D, Csaky KG, Cousins SW: Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2003, 44:3586–3592.PubMedCrossRef
92.
Combadiere C, Feumi C, Raoul W, Keller N, Rodero M, Pezard A, Lavalette S, Houssier M, Jonet L, Picard E, et al.: CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 2007, 117:2920–2928.PubMedPubMedCentralCrossRef
93.
Sakurai E, Anand A, Ambati BK, van Rooijen N, Ambati J: Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2003, 44:3578–3585.PubMedCrossRef
94.
Newman AM, Gallo NB, Hancox LS, Miller NJ, Radeke CM, Maloney MA, Cooper JB, Hageman GS, Anderson DH, Johnson LV, Radeke MJ: Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med 2012, 4:16.PubMedPubMedCentralCrossRef
95.
Kramer M, Hasanreisoglu M, Feldman A, Siegel RA, Sonis P, Maharshak I, Monselise Y, Gurevich M, Weinberger D: Monocyte chemoattractant protein-1 in the aqueous humor of patients with age-related macular degeneration. Clin Experiment Ophthalmol 2012, 40:617–12.PubMedCrossRef
96.
Jonas JB, Tao Y, Neumaier M, Findeisen P: Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch Ophthalmol 2010, 128:1281–1286.PubMedCrossRef
97.
Chen M, Muckersie E, Forrester JV, Xu H: Immune activation in retinal aging: a gene expression study. Invest Ophthalmol Vis Sci 2010, 51:5888–5896.PubMedCrossRef
98.
Luhmann UF, Robbie S, Munro PM, Barker SE, Duran Y, Luong V, Fitzke FW, Bainbridge JW, Ali RR, MacLaren RE: The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci 2009, 50:5934–5943.PubMedPubMedCentralCrossRef
99.
Tsutsumi C, Sonoda KH, Egashira K, Qiao H, Hisatomi T, Nakao S, Ishibashi M, Charo IF, Sakamoto T, Murata T, Ishibashi T: The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J Leukoc Biol 2003, 74:25–32.PubMedCrossRef
100.
Ambati J, Anand A, Fernandez S, Sakurai E, Lynn BC, Kuziel WA, Rollins BJ, Ambati BK: An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med 2003, 9:1390–1397.PubMedCrossRef
101.
Raoul W, Auvynet C, Camelo S, Guillonneau X, Feumi C, Combadiere C, Sennlaub F: CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration. J Neuroinflammation 2010, 7:87.PubMedPubMedCentralCrossRef
102.
Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, Elbashir S, Geick A, Hadwiger P, Harborth J, et al.: Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004, 432:173–178.PubMedCrossRef
103.
Whitehead KA, Langer R, Anderson DG: Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 2009, 8:129–138.PubMedCrossRef
104.
Shen J, Samul R, Silva RL, Akiyama H, Liu H, Saishin Y, Hackett SF, Zinnen S, Kossen K, Fosnaugh K, et al.: Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Ther 2006, 13:225–234.PubMedCrossRef
105.
Reich SJ, Fosnot J, Kuroki A, Tang W, Yang X, Maguire AM, Bennett J, Tolentino MJ: Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis 2003, 9:210–216.PubMed
106.
Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi JZ, Albuquerque RJ, Yamasaki S, Itaya M, Pan Y, et al.: Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 2008, 452:591–597.PubMedPubMedCentralCrossRef
Metadata
Title
Small interfering RNA-mediated suppression of Ccl2 in Müller cells attenuates microglial recruitment and photoreceptor death following retinal degeneration
Authors
Matt Rutar
Riccardo Natoli
Jan M Provis
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2012
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-9-221

Other articles of this Issue 1/2012

Journal of Neuroinflammation 1/2012 Go to the issue

Review

Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases

Research

Effects of dimethyl fumarate on neuroprotection and immunomodulation

Research

Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells

Research

IFN-γ protects from lethal IL-17 mediated viral encephalomyelitis independent of neutrophils

Research

Etiology of autistic features: the persisting neurotoxic effects of propionic acid

Research

CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species